Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 7 of 7 results for levothyroxine

  1. Thyroid disease: assessment and management (NG145)

    This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.

    NICE guideline
    Last updated
    12 October 2023
    View recommendations

    Sections for NG145

  2. Hypothyroidism: register (IND138)

    This indicator covers the contractor establishing and maintaining a register of patients with hypothyroidism who are currently treated with levothyroxine. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM99.

    General practice indicators suitable for use in QOF
    Last updated
    4 November 2020

  3. Hypothyroidism: annual thyroid function test (IND139)

    This indicator covers the percentage of patients with hypothyroidism, on the register, with thyroid function tests recorded in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM100

    General practice indicators suitable for use in QOF
    Last updated
    4 November 2020

  4. What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded sufficiently to T4 alone? Does DiO2 polymorphism affect the response to combination therapy with T4 and T3?

    NG145/1 Question What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination therapy compared...

    Research recommendation
    Published
    10 February 2020

  5. What is the clinical and cost effectiveness of levothyroxine for people under 65 with symptomatic subclinical hypothyroidism?

    NG145/7 Question What is the clinical and cost effectiveness of levothyroxine for people under 65 with symptomatic subclinical...

    Research recommendation
    Published
    10 February 2020

  6. Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (HTG416)

    Evidence-based recommendations on ultrasound-guided percutaneous radiofrequency ablation for treating benign thyroid nodules in adults. This involves using heat energy to destroy tissue in the nodules.

    HealthTech guidance
    Published
    22 June 2016
    View recommendations

    Sections for HTG416

  7. Fertility problems: assessment and treatment (NG257)

    This guideline covers diagnosing and treating health-related fertility problems. It aims to reduce variation in practice and improve how fertility problems are investigated and managed.

    NICE guideline
    Published
    31 March 2026

    Sections for NG257